Engineering Pathogen Specific High Affinity T-Cell Receptors Linked to Cytokines for Targeting of Antigen Presenting Cells
In February last year I was awarded an ORCA grant which turned out to be the starting of one of my biggest learning experiences here at BYU. My research mentor, Dr. Weber, and I work with the immune system. This semester I have been able to see firsthand exactly how things in my field are moved forw...
| Main Authors: | , |
|---|---|
| Format: | Text |
| Language: | unknown |
| Published: |
BYU ScholarsArchive
2014
|
| Subjects: | |
| Online Access: | https://scholarsarchive.byu.edu/jur/vol2014/iss1/783 https://scholarsarchive.byu.edu/context/jur/article/3122/viewcontent/auto_convert.pdf |
| Summary: | In February last year I was awarded an ORCA grant which turned out to be the starting of one of my biggest learning experiences here at BYU. My research mentor, Dr. Weber, and I work with the immune system. This semester I have been able to see firsthand exactly how things in my field are moved forward. Along with that I have learned many numerous, invaluable techniques that I will no doubt continue to use for many years to come through post undergraduate school along with my career. Also, I was able to work one on one with my research mentor; a learning experience in its self. For my grant proposal we wanted to learn and become familiar in techniques used at other universities to look at T cells and their receptors in order to look at a unique T cell receptor named LLO118. The overall goal was to use our acquired experience and skills to design a T cell receptor as a synthesized therapeutic. |
|---|